Regulatory Clarification from IOL Chemicals and Pharmaceuticals Limited
Summary of Company's Response
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has formally responded to a query from the National Stock Exchange of India Ltd. regarding a significant increase in the trading volume of its securities.
Date and Nature of Exchange Query
The communication is dated 11th November 2026 and is in response to the NSE's letter Ref. No. NSE/CM/Surveillance/17778 dated 9th November 2026.
Company's Clarification on Trading Volume
The company clarified that there is no information or event, including any impending announcement, which in its opinion may have a bearing on the price or volume behaviour of the company's shares. This clarification specifically addresses the significant increase in trading volume that prompted the NSE's inquiry.
Regulatory Compliance Reference
The company explicitly references its obligations under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It confirms that no information requiring disclosure under this regulation exists beyond what has already been disclosed to the stock exchanges.
Commitment to Future Disclosures
IOLCP reaffirmed its commitment to complying with all disclosure obligations under the SEBI LODR Regulations, 2015. The company stated it will continue to make necessary disclosures to the stock exchanges in a timely manner as and when any event or information requiring disclosure arises.